Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| APO-METOPROLOL SR | APOTEX INC | Actual shortage | 100MG | Updated Report | 2020-01-27 | 98569 |
| APIDRA | SANOFI-AVENTIS CANADA INC | Actual shortage | 100UNIT | Updated Report | 2020-01-27 | 99690 |
| ETIBI | BAUSCH HEALTH, CANADA INC. | Actual shortage | 400MG | Updated Report | 2020-01-27 | 85831 |
| ETIBI | BAUSCH HEALTH, CANADA INC. | Actual shortage | 100MG | Updated Report | 2020-01-27 | 85828 |
| MINT-FLUOXETINE | MINT PHARMACEUTICALS INC | Actual shortage | 20MG | Updated Report | 2020-01-27 | 57069 |
| MINT-LOSARTAN/HCTZ DS | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 100.0MG | Updated Report | 2020-01-27 | 80811 |
| MINT-LOSARTAN/HCTZ | MINT PHARMACEUTICALS INC | Resolved | 12.5MG 50MG | Updated Report | 2020-01-27 | 74450 |
| XYLOCAINE 1% | ASPEN PHARMACARE CANADA INC. | Actual shortage | 10MG | Updated Report | 2020-01-27 | 99693 |
| MINT-LOSARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 100MG | Updated Report | 2020-01-27 | 80808 |
| MINT-PIOGLITAZONE | MINT PHARMACEUTICALS INC | Actual shortage | 15MG | Updated Report | 2020-01-27 | 88502 |
| MINT-PIOGLITAZONE | MINT PHARMACEUTICALS INC | Actual shortage | 30MG | Updated Report | 2020-01-27 | 95924 |
| MINT-LOSARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG | Updated Report | 2020-01-27 | 71069 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 150.0MG | Updated Report | 2020-01-27 | 80792 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 300MG | Updated Report | 2020-01-27 | 80803 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 75MG | Updated Report | 2020-01-27 | 71063 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 150MG | Updated Report | 2020-01-27 | 80800 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 300.0MG | Updated Report | 2020-01-27 | 80797 |
| MINT-FLUOXETINE | MINT PHARMACEUTICALS INC | Actual shortage | 10MG | Updated Report | 2020-01-27 | 57064 |
| MINT-CIPROFLOX | MINT PHARMACEUTICALS INC | Actual shortage | 500MG | Updated Report | 2020-01-27 | 57055 |
| NARDIL | ERFA CANADA 2012 INC | Actual shortage | 15MG | New Report | 2020-01-27 | 104431 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| CIPRO | BAYER INC | To be discontinued | 500MG | Updated Report | 2020-01-27 | 96049 |
| AVELOX I.V. | BAYER INC | To be discontinued | 400MG | Updated Report | 2020-01-27 | 73405 |
| TENORETIC 100/25MG TAB | ASTRAZENECA CANADA INC | Reversed | 25MG 100MG | Updated Report | 2020-01-27 | 94999 |
| TENORETIC 50/25MG TAB | ASTRAZENECA CANADA INC | Reversed | 25MG 50MG | Updated Report | 2020-01-27 | 94996 |
| ACT LEVETIRACETAM | TEVA CANADA LIMITED | Discontinued | 500MG | New Report | 2020-01-24 | 104304 |
| ACT PAROXETINE | ACTAVIS PHARMA COMPANY | Discontinued | 20MG | New Report | 2020-01-24 | 104300 |
| TEVA-QUININE | TEVA CANADA LIMITED | Discontinued | 300MG | New Report | 2020-01-24 | 104294 |
| NOVAMOXIN | TEVA CANADA LIMITED | Discontinued | 250MG | New Report | 2020-01-24 | 104289 |
| TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Discontinued | 5MG | New Report | 2020-01-24 | 104283 |
| DEMEROL | SANOFI-AVENTIS CANADA INC | To be discontinued | 50MG | Updated Report | 2020-01-24 | 98380 |
| ACT OLANZAPINE ODT | TEVA CANADA LIMITED | Discontinued | 15MG | New Report | 2020-01-24 | 104277 |
| TUSSIONEX | SANOFI-AVENTIS CANADA INC | To be discontinued | 5MG 10MG | Updated Report | 2020-01-24 | 98368 |
| TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Discontinued | 5MG | New Report | 2020-01-24 | 104263 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | TEVA CANADA LIMITED | Discontinued | 300MG 150MG | New Report | 2020-01-24 | 104260 |
| TEVA-LISINOPRIL (TYPE P) | TEVA CANADA LIMITED | Discontinued | 20MG | New Report | 2020-01-24 | 104257 |
| DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 2.5G 15.2MG 23.9MG 567MG | Updated Report | 2020-01-23 | 91399 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 1.5G 5.08MG 18.3MG 538MG | Updated Report | 2020-01-23 | 91388 |
| TEVA-DEFERASIROX | TEVA CANADA LIMITED | Discontinued | 250MG | New Report | 2020-01-21 | 103796 |
| TEVA-DEFERASIROX | TEVA CANADA LIMITED | Discontinued | 125MG | New Report | 2020-01-21 | 103791 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | TEVA CANADA LIMITED | Discontinued | 0.004% | New Report | 2020-01-21 | 103788 |
